• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

QLTI:US

5.9500 USD 0.0500 0.85%

As of 20:10:00 ET on 04/22/2014.

Snapshot for QLT Inc (QLTI)

Open: 5.9500 Day's Range: 5.8900 - 6.0100 Volume: 18,476
Previous Close: 5.9000 52wk Range: 3.6900 - 7.1000 1-Yr Rtn: +35.13%

Stock Chart for QLTI

No chart data available.
  • QLTI:US 5.9500
  • 1D
  • 1M
  • 1Y
5.9000
Interactive QLTI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for QLTI

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.5000
Est. PEG Ratio -
Market Cap (M USD) 303.94
Shares Outstanding (M) 51.08
30 Day Average Volume 66,027
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 3.9153
Dividend Ex-Date 06/28/2013
5 Year Dividend Growth -
Next Earnings Announcement 05/02/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for QLTI

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for QLTI

QLT Inc. develops and commercializes pharmaceutical products for use in photodynamic therapy, the use of light activated drugs to treat disease. The Company's lead drug, Visudyne, is marketed by Novartis AG, and is used in the treatment of the wet form of age-related macular degeneration.

Jason M AryehChairmanSukhi JagpalChief Financial Officer
Alexander R LussowSenior VP:Business DevelopmentLinda M LupiniSenior VP:Human Resources
More Company Profile & Key Executives for QLTI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil